Rob Isackson is a partner in Venable's Intellectual Property Litigation practice and an experienced first chair trial attorney with a winning track record of resolving complex intellectual property disputes.
With a focus on patent and trade secret disputes and commercial disputes over technology issues, Mr. Isackson has served as lead counsel in more than 40 federal cases, and appears regularly in proceedings before the Patent and Trademark Office and international arbitration tribunals.
His work has involved some of the most complex and cutting-edge technologies for leading companies, ranging from Fortune 100 multinationals to emerging start-ups, including for clients such as Dow AgroSciences (matters involving genetically modified crops in the fields of applied molecular biology, biochemistry, plant genetics, DNA, and RNA); LG Electronics Inc. (mobile device and major appliance technologies); Bayer Healthcare LLC (patent and trade secrets issues concerning over-the-counter pharmaceuticals, consumer care, blood chemistry analyzers, and immunodiagnostic assay reagents and machines); Intel Corp. (parallel processing hardware and software); Cadent Ltd. (IP disputes concerning market leading digital dentistry and digital orthodontic technologies); and Naturex (enforcement of their rights in botanical dietary supplement products and brands).
